AR
Aridis Pharmaceuticals, Inc.
ARDS · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $17.8K
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Moderate
4/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 209.25%
Asset turnover 0.00x
ROIC 174.87%
Debt
50 /100
Moderate Int. coverage -79.35x
Net debt/EBITDA -0.04x
Current ratio 0.32x
Stability
53 /100
Moderate EPS volatility 48.54%
Profitable years 0
Beta 0.76x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ARDS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vu L. Truong
Employees
37
Headquarters
Los Gatos
Prihajajoči dogodki
02 NOV.
Earnings
Upcoming earnings report